register

Human Resources

Organon ushers in a new era of employee wellness

Health Industry Hub | March 2, 2023 |

Women’s healthcare company, Organon, has lifted the bar on workplace wellbeing and inclusion with the introduction of comprehensive and integrated Flexible Work and Lifestyle Policies in Australia. The policies are set to lead the way in creating a supported, flexible, and inclusive workplace for all employees, no matter what stage of life, gender or family situation.

Employees in Australia will now be offered ten (10) additional leave days per calendar year, to be tailored to suit individual needs. This leave has limitless options, and for example, can be used to extend personal leave, to care for a loved one, to support employees and their families during a life stage, or for self-care. The ten days leave is in addition to all existing benefits, and ad-hoc leave days provided by the company, such as company-wide wellbeing day gifted to all employees for International Women’s Day on March 8.

Organon is also introducing a new Fertility Reimbursement Policy, which will support employees to be reimbursed up to $3000 per year for Fertility and Assisted Reproductive treatments and procedures. This applies to the employee, or the employee’s spouse or partner, and is backdated to April 2022 to accommodate employees who may have already commenced this treatment.

Omnichannel and CX: AbbVie’s digital leader talks the next steps for industry

Organon has also extended its Compassionate Leave Benefits to two (2) calendar weeks to support employees during the loss of someone in their immediate family, and introduced a new Pregnancy Loss Leave of up to six (6) weeks, to support any pregnant employee who experiences a miscarriage.

Nirelle Tolstoshev, Organon Australia Managing Director, said the company wanted to demonstrate their leadership and commitment to a People First culture by building on Organon’s already progressive benefits package, to create an even more flexible and balanced working environment for every employee.

“Our new Flexible Work and Lifestyle Benefits are founded on concepts of belonging, respect, and wellbeing. These new policies recognise that there is no one size fits all, and actively supporting the diverse needs of our people is our way of ensuring that we are living up to Organon’s value of ‘we all belong’. In designing this full package of policies, we challenged ourselves to be innovative and courageous to create work practices that allow every colleague to feel safe, respected and connected to our People First culture,” said Ms Tolstoshev.

Christina David, Senior Specialist, Drug Safety, said “My brother is marrying in India this year, and it’s an important time for him and my family to come together. I had already booked all my available leave to attend the wedding with my family in India. When this opportunity for an extra 10 days’ leave was provided, it meant that I was able to also book a cruise with my son to celebrate his significant birthday. Organon’s new leave enhancement policy has made it possible for me to balance my career with my whole family and strengthening my connection with my family in India, bringing them a little closer to home.”

To design the new Flexible Work and Lifestyle Policies, Organon Australia drew on the results of two global employee surveys of Organon employees conducted in 2022.

Sophie Althans, HR Director at Organon Australia said the survey results provided valuable insights – with themes around additional paid leave for personal priorities and work/life balance with increases in metrics regarding respect, inclusion and wellbeing at work. One consistent theme was that the existing benefits seemed to be more focused on parents, and in some cases weren’t as inclusive of the diversity of their people. Organon looked at how the company could broaden the scope of the benefits, to support employees no matter what stage of life they are at.

“As a leading company dedicated to the health of women as the foundation of a strong and healthy society, diversity is in our DNA. That’s why we want to be able to support our people when they need it the most, and these new policies reflect that promise. I’m proud of our unique and encompassing Flexible Work and Lifestyle Benefits, which helps us create a great place to work, with equal opportunity for all our people to grow, develop and succeed. It reflects our commitment at Organon to creating an inclusive environment, where everyone feels valued and respected,” said Althans.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.